Generic Drugmakers to Inherit Safety Labeling Update Powers Under FDA Rule

Generic Line
A A
The FDA is proposing to give generic drugmakers the power to revise product labeling in response to safety issues prior to agency approval — a power that brand drugmakers already have.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00